CKD (Chronic Kidney Disease) Stage 5D Clinical Trial
Official title:
Impact of Propionic Acid on Regulatory T Cell Function in Children With Chronic Kidney Disease
Pro-Kids is a multi-center, double-blind, randomized and placebo-controlled intervention study in children with chronic kidney disease. The investigators address the effect of a dietary food supplementation of propionic acid on the immune system and the function of the intestinal barrier in CKD patients treated with hemodialysis.
Chronic inflammation is a major risk factor of cardiovascular disease progression in CKD, irrespective of confounding comorbidities. Based on current knowledge, microbially-derived metabolites such as short chain fatty acids (SCFA) play an important role in the regulation of chronic inflammatory processes in CKD patients. Children with CKD are known to have reduced serum levels of the SCFA propionic acid (PA), as a consequence of both gut microbial dysbiosis and reduced fiber intake. In animal and human studies the impact of PA on function and abundance of regulatory T cells (Treg) has been demonstrated. Consequently, the investigators aim to normalize the PA serum levels by oral PA food supplementation in hemodialysis patients in order to mitigate chronic inflammation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04083664 -
NGAL and Hepcidin Levels in Hemodialysis Patients in Assiut University Hospital
|
||
| Not yet recruiting |
NCT04538443 -
Impact of CKD on Children and Their Families
|
||
| Recruiting |
NCT06416761 -
Genetics in the Progression of Nephropathies
|
||
| Recruiting |
NCT04381143 -
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
|
Phase 4 | |
| Active, not recruiting |
NCT03350425 -
Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients
|